Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Y Chiang

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Journal of Biopharmaceutical Statistics|February 26, 2026
Applications of correlative analysis for chemistry, manufacturing and controls in cell and gene therapySangwook Choi, Alan Y Chiang, Catherine Cheng, et al.
Clinical and Translational Science|June 20, 2023
Abemaciclib does not increase the corrected QT interval in healthy participantsJill C Chappell, Alan Y Chiang, Jane Royalty, et al.
Archives of Endocrinology and Metabolism|February 25, 2016
Incidence of vertebral fractures in calcium and vitamin D-supplemented postmenopausal Brazilian women with osteopenia or osteoporosis: data from Arzoxifene Generations TrialHenrique Pierotti Arantes, Suely Godoy Agostinho Gimeno, Alan Y Chiang, et al.
Journal of Pharmacological and Toxicological Methods|June 26, 2007
ILSI-HESI cardiovascular safety subcommittee dataset: an analysis of the statistical properties of QT interval and rate-corrected QT interval (QTc)Alan Y Chiang, Alan S Bass, Murray M Cooper, et al.
Journal of Biopharmaceutical Statistics|March 12, 2026
Advancing cell and gene therapy: Application of AI/ML in clinical development and patient managementKelly Speth, Sanhita Sengupta, Md Shamsuzzaman, et al.
Toxicologic Pathology|March 4, 2020
Scientific Regulatory Policy Committee Points to Consider*: Nuisance Factors, Block Effects, and Batch Effects in Nonclinical Safety Assessment StudiesAlbert Eric Schultze, Bindu Bennet, Jessica Caverly Rae, et al.
Journal of Pharmacological and Toxicological Methods|October 30, 2020
Use of the ZDF rat to model dietary fat induced hypercoagulability is limited by progressive and fatal nephropathyMichael K Pugsley, Marjory B Brooks, Cindy E Fishman, et al.
Toxicologic Pathology|August 25, 2009
Kainic acid-induced F-344 rat model of mesial temporal lobe epilepsy: gene expression and canonical pathwaysAlok K Sharma, George H Searfoss, Rachel Y Reams, et al.
Clinical Pharmacology and Therapeutics|November 19, 2018
Abemaciclib Inhibits Renal Tubular Secretion Without Changing Glomerular Filtration RateJill C Chappell, P Kellie Turner, Y Anne Pak, et al.
Journal of Pharmacological and Toxicological Methods|March 6, 2018
The evaluation of endpoint variability and implications for study statistical power and sample size in conscious instrumented dogsAlan Y Chiang, Brian D Guth, Michael K Pugsley, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Journal of Biopharmaceutical Statistics|February 26, 2026
Applications of correlative analysis for chemistry, manufacturing and controls in cell and gene therapySangwook Choi, Alan Y Chiang, Catherine Cheng, et al.
Clinical and Translational Science|June 20, 2023
Abemaciclib does not increase the corrected QT interval in healthy participantsJill C Chappell, Alan Y Chiang, Jane Royalty, et al.
Archives of Endocrinology and Metabolism|February 25, 2016
Incidence of vertebral fractures in calcium and vitamin D-supplemented postmenopausal Brazilian women with osteopenia or osteoporosis: data from Arzoxifene Generations TrialHenrique Pierotti Arantes, Suely Godoy Agostinho Gimeno, Alan Y Chiang, et al.
Journal of Pharmacological and Toxicological Methods|June 26, 2007
ILSI-HESI cardiovascular safety subcommittee dataset: an analysis of the statistical properties of QT interval and rate-corrected QT interval (QTc)Alan Y Chiang, Alan S Bass, Murray M Cooper, et al.
Journal of Biopharmaceutical Statistics|March 12, 2026
Advancing cell and gene therapy: Application of AI/ML in clinical development and patient managementKelly Speth, Sanhita Sengupta, Md Shamsuzzaman, et al.
Toxicologic Pathology|March 4, 2020
Scientific Regulatory Policy Committee Points to Consider*: Nuisance Factors, Block Effects, and Batch Effects in Nonclinical Safety Assessment StudiesAlbert Eric Schultze, Bindu Bennet, Jessica Caverly Rae, et al.
Journal of Pharmacological and Toxicological Methods|October 30, 2020
Use of the ZDF rat to model dietary fat induced hypercoagulability is limited by progressive and fatal nephropathyMichael K Pugsley, Marjory B Brooks, Cindy E Fishman, et al.
Toxicologic Pathology|August 25, 2009
Kainic acid-induced F-344 rat model of mesial temporal lobe epilepsy: gene expression and canonical pathwaysAlok K Sharma, George H Searfoss, Rachel Y Reams, et al.
Clinical Pharmacology and Therapeutics|November 19, 2018
Abemaciclib Inhibits Renal Tubular Secretion Without Changing Glomerular Filtration RateJill C Chappell, P Kellie Turner, Y Anne Pak, et al.
Journal of Pharmacological and Toxicological Methods|March 6, 2018
The evaluation of endpoint variability and implications for study statistical power and sample size in conscious instrumented dogsAlan Y Chiang, Brian D Guth, Michael K Pugsley, et al.
Pageof 3